Trials / Conditions / Peripheral Vascular Disease

Peripheral Vascular Disease

194 registered clinical trials studyying Peripheral Vascular Disease — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	EVERO Drug-coated Balloon (DCB) Randomized Trial NCT07144150	Cook Research Incorporated	N/A
Recruiting	Observing the Role of Inflammation in Peripheral Artery Disease and Its Impact on Heart and Mobility Health: P NCT07500610	Cardiology Research UBC	—
Recruiting	Improving Mobility After Revascularization in Peripheral Artery Disease NCT06686121	Northwestern University	Phase 3
Not Yet Recruiting	Mobility Assessment in Multi-morbidity NCT06473168	Northumbria University	—
Not Yet Recruiting	Colonoscopy and Antiplatelet Therapy Trial NCT06613191	Ochsner Health System	Phase 4
Recruiting	Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease NCT06389149	University of Nebraska	N/A
Recruiting	ENhancing Exercise With LIGHT to Improve Functioning in PAD NCT06399900	Northwestern University	N/A
Recruiting	Treatment of TASC C and D Aortoiliac Lesions NCT06253312	Clinical Centre of Serbia	—
Recruiting	Far Red Light to Improve Functioning in PAD NCT06165016	Northwestern University	N/A
Unknown	Evaluation of an Electronic Health Record-based Screening Tool for Peripheral Artery Disease NCT04054232	Stanford University	N/A
Completed	Impedance Sensor Evaluated in Peripheral Artery Disease for Tissue Detection NCT06112054	Sensome	N/A
Completed	Guided Meditation to Decrease Perioperative Anxiety and Increase Patient Intraoperative Compliance in Vascular NCT05837481	Massachusetts General Hospital	N/A
Completed	Effect of Plasma Ceramides on Peripheral Vascular Function NCT05107869	Medical College of Wisconsin	N/A
Unknown	Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE) NCT05335525	Terumo Europe N.V.	—
Completed	BOLT Lithotripsy RESTORE BTK Trial NCT05535907	Bolt Medical	N/A
Completed	The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with PAD NCT04937179	University of Illinois at Chicago	N/A
Completed	Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European St NCT05027698	Terumo Europe N.V.	—
Active Not Recruiting	Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? NCT05804097	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 4
Completed	Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial NCT04283994	University of Washington	N/A
Terminated	Safety and Efficacy of the URECA CTO Device NCT04385381	Ureca BV	N/A
Completed	Muscle Perfusion in Patients With PAD by Non-invasive MSOT NCT04641091	University Hospital Erlangen	—
Unknown	Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis NCT04238923	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 2 / Phase 3
Completed	Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) NCT04281784	University of Washington	N/A
Completed	Preoperative Continuous Sciatic Perineural Analgesia in Patients Undergoing Lower Limb Revascularization NCT04286971	Hospital Municipal Miguel Couto	—
Withdrawn	Blood Flow Changes in Femoral-popliteal Bypass Grafts After Neuromuscular Electrical Stimulation (NMES). NCT04109287	Imperial College Healthcare NHS Trust	N/A
Unknown	PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Is NCT03970538	LimFlow, Inc.	N/A
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) NCT04274049	Beijing Northland Biotech. Co., Ltd.	Phase 3
Terminated	Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication NCT04100681	Otivio AS	N/A
Terminated	The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions NCT04007055	Marissa Jarosinski	Phase 3
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) NCT04275323	Beijing Northland Biotech. Co., Ltd.	Phase 3
Unknown	The VaSecure BTK Study NCT03638115	Vascuros Medical Pte Ltd	N/A
Completed	Project to Improve Communication About Serious Illness - Pilot Study NCT03746392	University of Washington	N/A
Completed	Ischemic Preconditioning Claudication Study NCT03511157	Medical College of Wisconsin	N/A
Completed	JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Ba NCT03206762	Midwest Cardiovascular Research Foundation	N/A
Unknown	Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Isch NCT02993809	South China Research Center for Stem Cell and Regenerative Medicine	Phase 1
Unknown	Motivating Structured Walking Activity in Intermittent Claudication NCT03238222	Guy's and St Thomas' NHS Foundation Trust	N/A
Completed	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon NCT03241459	SurModics, Inc.	N/A
Completed	A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation NCT02685098	Indiana University	Phase 1
Completed	VQI DELTA Paclitaxel Device Safety Analysis NCT04110288	Lahey Clinic	—
Unknown	Absorbable Sutures in Vascular Surgery NCT02935127	University of Catanzaro	N/A
Completed	The DESappear Study: Drug Eluting Scaffold NCT02869087	Elixir Medical Corporation	N/A
Unknown	Determining Predictors of Restenosis in Femoropopliteal Lesions NCT02734095	University of Campinas, Brazil	N/A
Completed	Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers NCT03028285	POLYSAN Scientific & Technological Pharmaceutical Company	Phase 1
Terminated	Prehabilitation for PAD Revascularization Patients NCT02767895	University of Michigan	N/A
Completed	Tele-Health Electronic Monitoring to Reduce Post Discharge Complications and Surgical Site Infections NCT02767011	CAMC Health System	N/A
Completed	BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease NCT02655887	C. R. Bard	N/A
Active Not Recruiting	BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) NCT02805023	BioGenCell Ltd.	Phase 1 / Phase 2
Completed	DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions NCT02850107	VIVA Physicians	N/A
Completed	Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment NCT02834221	Kenichiro Yamagata	N/A
Completed	Vorapaxar on Thrombin Generation and Coagulability NCT03207451	Inova Health Care Services	Phase 4
Unknown	Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications NCT02834858	Jie Shen	Phase 1
Terminated	Oral Nutritional Supplement in Reducing Surgical Site Infections NCT02475525	University of Limerick	N/A
Completed	The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the NCT02464501	Horizons International Peripheral Group	N/A
Active Not Recruiting	Shockwave Therapy in Lower Limb Intermittent Calf Claudication NCT02652078	Hull University Teaching Hospitals NHS Trust	N/A
Completed	A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction NCT02418156	Elutia Inc.	—
Completed	The COPPER-B Trial NCT02395744	Horizons International Peripheral Group	N/A
Unknown	A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications NCT02796079	Jie Shen	Phase 1
Unknown	A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot NCT02831075	Jie Shen	Phase 1
Completed	Atherectomy By Laser Ablation With Turbo-Elite NCT02307370	Spectranetics Corporation	N/A
Completed	Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication NCT02436200	Imperial College London	N/A
Completed	Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC NCT02429310	Imperial College London	N/A
Terminated	Exparel as a Nerve Block for Severe Hand Pain NCT02374320	Jose Soberon, MD	Phase 2 / Phase 3
Completed	Zilver PTX Delivery System NCT02271529	Cook Group Incorporated	N/A
Completed	BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease NCT02228564	C. R. Bard	N/A
Unknown	Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating NCT01903044	Pontifícia Universidade Católica do Paraná	Phase 1 / Phase 2
Completed	Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlu NCT02212626	Flanders Medical Research Program	Phase 4
Unknown	The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-elutin NCT01952457	Flanders Medical Research Program	Phase 4
Completed	Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System NCT02211716	Flanders Medical Research Program	Phase 4
Completed	Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Ste NCT02211664	Flanders Medical Research Program	Phase 4
Completed	Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatme NCT02458911	iVascular S.L.U.	—
Terminated	Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System NCT02369692	Hansen Medical	—
Completed	Pilot Safety Study of Injectable SIS for Critical Limb Ischemia NCT02145845	Cook Group Incorporated	N/A
Withdrawn	Telerobotic Ultrasound for Carotid Imaging - Feasibility Study NCT05654935	Rush University Medical Center	—
Completed	Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial NCT02129127	TriReme Medical, LLC	N/A
Completed	The Effect of Heat on Blood and Oxygen Flow Readings Part 2 NCT01992939	VA Pittsburgh Healthcare System	N/A
Terminated	Registry of the Magellan Robotic System NCT01984437	Hansen Medical	—
Completed	Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With NCT01872208	Humacyte, Inc.	N/A
Unknown	RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty NCT02054871	Mid Western Regional Hospital, Ireland	N/A
Completed	Effect of Nike FuelBand on Exercise and Function in Claudicants; a Randomised Controlled Trial NCT01822457	Imperial College London	N/A
Completed	Platelet Activity in Vascular Surgery for Thrombosis and Bleeding NCT01897103	NYU Langone Health	—
Withdrawn	Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting NCT01803165	University of Nebraska	—
Unknown	Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites NCT01983215	Dr. Jean E. Starr, MD	N/A
Completed	Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging NCT01522495	Georgetown University	N/A
Completed	Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" NCT02786173	Metro Health, Michigan	—
Completed	Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal NCT01938391	Abbott Medical Devices	N/A
Withdrawn	Popliteal Artery of Treatment With Balloon Angioplasty vs. SUPERA VERITAS Peripheral Stent System NCT01667393	Abbott Medical Devices	N/A
Completed	Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose NCT01543555	Hospital do Coracao	Phase 3
Completed	Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot S NCT01784471	Yaffa Golan, Ltd.	N/A
Unknown	Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe NCT01661231	Biotronik AG	N/A
Completed	JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions NCT01722877	Midwest Cardiovascular Research Foundation	N/A
Completed	Tack Optimized Balloon Angioplasty (TOBA) Study NCT01663818	Philips Clinical & Medical Affairs Global	N/A
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia NCT01548378	Beijing Northland Biotech. Co., Ltd.	Phase 2
Completed	ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System NCT01468974	Abbott Medical Devices	N/A
Terminated	The ABSORB BTK (Below The Knee) Clinical Investigation NCT01341340	Abbott Medical Devices	N/A
Completed	Absolute Pro® MOMENTUM™ NCT01444378	Abbott Medical Devices	N/A
Completed	Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System NCT01355406	Cordis US Corp.	N/A
Completed	Near Infrared Spectroscopy and Transcutaneous Oxygen Pressure in Critical Limb Ischemia Before and After Treat NCT01459341	Carmel Medical Center	—
Completed	Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents NCT01319812	Biotronik, Inc.	Phase 2
Completed	Effects of Paclitaxel on Intimal Hyperplasia NCT01454778	Patrick Kelly	N/A
Completed	PF-00489791 For The Treatment Of Raynaud's NCT01090492	Pfizer	Phase 2
Completed	Endovascular Atherectomy Safety and Effectiveness Study NCT01541774	AtheroMed, Inc	Phase 3
Completed	A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery NCT01118117	Terumo Medical Corporation	N/A
Completed	4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Dis NCT01413139	Flanders Medical Research Program	Phase 4
Completed	Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study. NCT01161251	University of Roma La Sapienza	—
Completed	Bard® LifeStent® Vascular Stent Delivery System Study NCT01179984	C. R. Bard	N/A
Terminated	Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (C NCT01049919	Zimmer Biomet	N/A
Completed	The Evicel Post-Authorization Surveillance Study NCT01158261	Ethicon, Inc.	—
Completed	GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Resten NCT01108861	Flanders Medical Research Program	Phase 4
Completed	Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium NCT01404078	St. John's Research Institute	N/A
Terminated	Clinical Pilot-Study of ProEndoTecc Vascular Grafts as Superficial Femoral Artery Bypass / Interponate NCT01095237	NonWoTecc Medical GmbH	N/A
Unknown	Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery NCT01083394	Deutsches Herzzentrum Muenchen	Phase 4
Active Not Recruiting	Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia NCT00956332	MultiGene Vascular Systems Ltd.	Phase 1 / Phase 2
Completed	Physical Activity, Function and Quality of Life in Patients After Endovascular Treatment NCT01109732	Oslo University Hospital	N/A
Completed	TomVasc - Vascular Effects of Tomato Extract NCT01100385	Cambridge University Hospitals NHS Foundation Trust	N/A
Completed	Registry of AngioJet Use in the Peripheral Vascular System NCT01086215	Boston Scientific Corporation	—
Completed	Standard Balloon Angioplasty Versus Angioplasty With a Paclitaxel-eluting Balloon for Femoral Artery In-stent NCT01305070	Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.	Phase 4
Completed	Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemi NCT00951210	Pluristem Ltd.	Phase 1
Completed	Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery NCT00933270	Abbott Medical Devices	N/A
Unknown	VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management NCT00970892	Ankara University	—
Completed	Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia NCT00919958	Pluristem Ltd.	Phase 1
Completed	A Study to Collect Intravascular Ultrasound Images Before and After Treatment With the Jetstream System NCT00911417	Pathway Medical Technologies Inc.	Phase 4
Unknown	SAMBA EU Femoropopliteal Trial NCT01139177	NovoStent Corporation	N/A
Completed	Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subject NCT00844532	Abbott Medical Devices	Phase 3
Completed	Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in S NCT01396525	Abbott Medical Devices	Phase 3
Terminated	Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty NCT01150617	IRCCS San Raffaele	Phase 4
Completed	Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions NCT00764777	Flanders Medical Research Program	Phase 4
Completed	The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions NCT00814970	Medtronic Endovascular	N/A
Completed	Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease NCT00827853	North Texas Veterans Healthcare System	N/A
Terminated	Data Registry Following Patients Using Supera Stent in the Femoral Arteries NCT01154751	Abbott Medical Devices	N/A
Completed	The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study NCT00753337	Medtronic Endovascular	N/A
Completed	Evaluation of Cilostazol in Combination With L-Carnitine NCT00822172	Colorado Prevention Center	Phase 4
Completed	Placement of Peripherally Inserted Central Venous Catheters (PICC) in Children Guided by Ultrasound NCT01279642	Federal University of São Paulo	N/A
Completed	Angio-Seal Evolution Device Registry NCT00817349	Abbott Medical Devices	—
Completed	Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia NCT00721006	TCA Cellular Therapy	Phase 2
Completed	Non-Contrast Enhanced Peripheral Magnetic Resonance Angiography NCT02823444	University of Utah	—
Completed	Femoral Arterial Access With Ultrasound Trial NCT00667381	University of California, Irvine	N/A
Completed	Drug Eluting Stents In The Critically Ischemic Lower Leg NCT00510393	Flanders Medical Research Program	Phase 2
Completed	DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions NCT00637741	Flanders Medical Research Program	Phase 4
Completed	Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia NCT00616980	Losordo, Douglas, M.D.	Phase 1 / Phase 2
Completed	The Complete® Self-Expanding Stent and Stent Delivery System Registry NCT00730730	Medtronic Endovascular	N/A
Completed	Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg NCT00538226	Rosenblum, Jonathan I., DPM	Phase 1
Completed	Atrium iCAST Iliac Stent Pivotal Study NCT00593385	Atrium Medical Corporation	N/A
Withdrawn	Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities NCT00751283	Vessix Vascular, Inc	Phase 2 / Phase 3
Terminated	Multicenter Assessment of the Safety and Efficacy of the Minnow Medical GRST™ Peripheral Catheter System NCT00881257	Vessix Vascular, Inc	Phase 2 / Phase 3
Unknown	PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia NCT00471289	Netherlands Society for Interventional Radiology	Phase 2 / Phase 3
Completed	Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Arte NCT00496041	University Hospital, Ghent	N/A
Completed	Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia NCT00518401	TCA Cellular Therapy	Phase 1
Unknown	Evaluation of the Clinical Significance of Fluorescence Videoangiography With Indocyanine-Green NCT00876668	Johann Wolfgang Goethe University Hospital	—
Completed	Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Inte NCT00481741	University of Rochester	Phase 4
Completed	A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System NCT00475566	Abbott Medical Devices	N/A
Unknown	Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia NCT00434616	Franziskus-Krankenhaus	Phase 2 / Phase 3
Terminated	Study to Evaluate Safety & Effectiveness of Vascular Sealant System NCT00439309	Integra LifeSciences Corporation	N/A
Terminated	FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease NCT00274157	The Cleveland Clinic	—
Completed	Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascula NCT00431249	Tungs' Taichung Metroharbour Hospital	Phase 4
Unknown	A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for NCT00519961	Hoffmann-La Roche	N/A
Completed	Crossover Study With MultiHance vs a Comparator for Peripheral MRA NCT00408083	Bracco Diagnostics, Inc	Phase 3
Unknown	RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic NCT00385385	ActivBiotics	Phase 2
Completed	ALD-301 for Critical Limb Ischemia, Randomized Trial NCT00392509	Aldagen	Phase 1 / Phase 2
Terminated	The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes NCT00456105	University of British Columbia	N/A
Terminated	Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia NCT00300040	Biopure Corporation	Phase 2
Completed	Zilver® PTX™ Global Registry NCT01094678	Cook Group Incorporated	N/A
Terminated	Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery NCT00328094	Beth Israel Deaconess Medical Center	N/A
Completed	RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System NCT00736086	Abbott Medical Devices	—
Completed	Testosterone for Peripheral Vascular Disease NCT00504712	Barnsley Hospital	Phase 4
Completed	Testosterone Replacement in Diabetes With Vascular Disease (Version 2) NCT00355537	Barnsley Hospital	Phase 4
Completed	Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Pati NCT00189540	AnGes USA, Inc.	Phase 2
Completed	Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures NCT00154141	Ethicon, Inc.	Phase 3
Completed	Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease NCT00113009	Valentis	Phase 2
Completed	Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermi NCT00117650	Genzyme, a Sanofi Company	Phase 2
Terminated	Prime Time for Superficial Femoral Artery (SFA) - The SFA Study NCT00902317	Arizona Heart Institute	N/A
Completed	Stem Cell Injection for Peripheral Vascular Disease NCT00278603	Northwestern University	Phase 1
Completed	Systematic Assessment of Vascular Risk NCT00378040	University Health Network, Toronto	—
Completed	The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudicatio NCT00071266	Kos Pharmaceuticals	Phase 3
Completed	Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) NCT00574782	AstraZeneca	—
Completed	Trial of VLTS-589 in Subjects With Intermittent Claudication NCT00068133	Valentis	Phase 2
Terminated	Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial NCT00437905	Medical University of Vienna	Phase 4
Completed	Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observationa NCT00660764	AstraZeneca	—
Completed	Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia NCT00060892	AnGes USA, Inc.	Phase 2
Completed	Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication NCT00102050	Nissan Chemical Industries	Phase 2
Terminated	Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft NCT00067041	United Therapeutics	Phase 2 / Phase 3
Completed	Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structu NCT00185276	Bayer	Phase 3
Unknown	Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease NCT00053716	Endovasc	Phase 2
Terminated	Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures NCT00060996	United Therapeutics	Phase 3
Completed	Association of Long-term Conditions With Survival Following Heart Attack in England and Wales NCT03037255	Marlous Hall	—
Completed	Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Cl NCT00062556	Kos Pharmaceuticals	Phase 3
Completed	Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets ( NCT00442845	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets NCT00442325	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arteri NCT00059657	Tanabe Pharma Corporation	Phase 3
Terminated	Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arteri NCT00059644	Tanabe Pharma Corporation	Phase 3
Completed	Oslo Balloon Angioplasty Versus Conservative Treatment NCT00222196	Ullevaal University Hospital	N/A
Completed	Extract of Ginkgo Biloba (EGB 761) and Vascular Function NCT00029991	National Center for Complementary and Integrative Health (NCCIH)	Phase 1 / Phase 2
Completed	Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angio NCT00004549	National Heart, Lung, and Blood Institute (NHLBI)	Phase 1
Enrolling By Invitation	Registry of Cardiovascular Disease Patients NCT01759225	Maccabi Healthcare Services, Israel	—
Unknown	New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease NCT01514916	Ab Medica Spa	N/A